Shandong Buchang Pharmaceuticals Co., Ltd. (603858) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Shandong Buchang Pharmaceuticals Co., Ltd.

Why is Shandong Buchang Pharmaceuticals Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of -5.47% and Operating profit at -44.63% over the last 5 years

With a growth in Net Profit of 4.29%, the company declared Very Positive results in Mar 25

RAW MATERIAL COST(Y) Fallen by -11.8% (YoY)
OPERATING PROFIT(Q) Highest at CNY 377.47 MM
PRE-TAX PROFIT(Q) Highest at CNY 373.97 MM

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of -0.59%, its profits have fallen by -218.2%
At the current price, the company has a high dividend yield of 0

Consistent Underperformance against the benchmark over the last 3 years

Along with generating -0.59% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in each of the last 3 annual periods

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Shandong Buchang Pharmaceuticals Co., Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Shandong Buchang Pharmaceuticals Co., Ltd. for you?

Low Risk, Medium Return

Absolute

Risk Adjusted

Volatility

Shandong Buchang Pharmaceuticals Co., Ltd.

-0.59%

0.50

23.45%

China Shanghai Composite

14.77%

1.01

14.58%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-5.47%

EBIT Growth (5y)

-44.63%

EBIT to Interest (avg)

9.21

Debt to EBITDA (avg)

1.59

Net Debt to Equity (avg)

0.18

Sales to Capital Employed (avg)

0.82

Tax Ratio

100.00%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

8.76%

ROE (avg)

7.29%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

1.88

EV to EBIT

181.19

EV to EBITDA

30.70

EV to Capital Employed

1.76

EV to Sales

1.97

PEG Ratio

Dividend Yield

ROCE (Latest)

0.97%

ROE (Latest)

-2.77%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

22What is working for the Company

RAW MATERIAL COST(Y)

Fallen by -11.8% (YoY

OPERATING PROFIT(Q)

Highest at CNY 377.47 MM

PRE-TAX PROFIT(Q)

Highest at CNY 373.97 MM

NET PROFIT(Q)

Highest at CNY 305.66 MM

EPS(Q)

Highest at CNY 0.29

-32What is not working for the Company

NET PROFIT(HY)

At CNY -561.63 MM has Grown at -620.6%

INTEREST(HY)

At CNY 63.56 MM has Grown at 16.79%

NET SALES(HY)

At CNY 5,195.41 MM has Grown at -10.55%

INVENTORY TURNOVER RATIO(HY)

Lowest at 0.99%

Here's what is working for Shandong Buchang Pharmaceuticals Co., Ltd.

Pre-Tax Profit

At CNY 373.97 MM has Grown at 493.65%

over average net sales of the previous four periods of CNY -95 MM

MOJO Watch

Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (CNY MM)

Pre-Tax Profit

At CNY 373.97 MM has Grown at 493.65%

over average net sales of the previous four periods of CNY -95 MM

MOJO Watch

Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (CNY MM)

Net Profit

At CNY 305.66 MM has Grown at 320.72%

over average net sales of the previous four periods of CNY -138.48 MM

MOJO Watch

Near term Net Profit trend is very positive

Net Profit (CNY MM)

Net Profit

At CNY 305.66 MM has Grown at 320.72%

over average net sales of the previous four periods of CNY -138.48 MM

MOJO Watch

Near term Net Profit trend is very positive

Net Profit (CNY MM)

Operating Profit

Highest at CNY 377.47 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is positive

Operating Profit (CNY MM)

Operating Profit

Highest at CNY 377.47 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is positive

Operating Profit (CNY MM)

Pre-Tax Profit

Highest at CNY 373.97 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Pre-Tax Profit

Highest at CNY 373.97 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit

Highest at CNY 305.66 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

Net Profit

Highest at CNY 305.66 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

EPS

Highest at CNY 0.29

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (CNY)

EPS

Highest at CNY 0.29

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (CNY)

Raw Material Cost

Fallen by -11.8% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Raw Material Cost

Fallen by -11.8% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Shandong Buchang Pharmaceuticals Co., Ltd.

Interest

At CNY 63.56 MM has Grown at 16.79%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Interest

At CNY 63.56 MM has Grown at 16.79%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Net Sales

At CNY 5,195.41 MM has Grown at -10.55%

Year on Year (YoY)

MOJO Watch

Near term sales trend is negative

Net Sales (CNY MM)

Net Sales

At CNY 5,195.41 MM has Grown at -10.55%

Year on Year (YoY)

MOJO Watch

Near term sales trend is negative

Net Sales (CNY MM)

Inventory Turnover Ratio

Lowest at 0.99%

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Lowest at 0.99%

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio